Join our Team!

We are looking for candidates to join our New York-based team Senior Account Executive or Account Supervisor We are seeking a mid-level (SAE/AS+) corporate communications/media relations professional. As a manager, you will be responsible for serving both as an account/project manager and as an individual contributor for several biotech clients that have specific corporate communication, financial communication, and media relations needs. Specific responsibilities may include account management activities such as budgetary planning, new business pitches, designing and executing media campaigns and leading/mentoring junior staff. Specific media relations responsibilities will include cultivating media relationships for our biotech and specialty pharma clients, creating compelling story angles and ideas, pitching news stories to traditional and online media, and leveraging social media; responding to media inquiries and writing and distributing media materials such as press releases. Job Requirements Qualified candidates should have a proven track record of media relations results, some established media relationships, excellent writing and editing skills, and a strong interest in science and medicine. A bachelor’s degree and a minimum of 5 years of communications/public relations experience, ideally in an agency setting, with an emphasis on media relations is also required. Financial communications experience a plus. To inquire, please send a resume and cover letter, in confidence, to: .(JavaScript must be enabled to view this email address)

Taking your medicine, naturally

Our firm, in attending the American College of Rheumatology meeting last week, learned once again to eat our fruit. Not that we needed to be reminded.  But on the topic of gout, that painful arthritic condition that is said to be on an upswing, it was reported at ACR that a cup of cherries daily may reduce the associated painful flares, often of a big toe, that lead patients to seek treatment.  It seems that cherries contain anthocyanins, an antioxidant, that is credited with reducing flares before they begin.  According to the study, those who ate about one cup of…Read More…

Ingredients for Success in Biotech

10 years ago, on October 30, 2000, on behalf of a U.K. client, we announced a partnership between two biotechnology companies promising to develop a monoclonal antibody for an exciting new target that emerged from research into the human genome.  At the time, just prior to the hype and promise of a fully sequenced human genome, we called this new target a “validated target.”  Of course all pursued targets were “validated,” in our minds (and in our press releases).  I once asked a science writer to define what a validated target meant to him.  His answer was that it is…Read More…